Company Results (84

Royal Enfield recorded a strong 22% rise in sales during November, underscoring sustained demand for mid-weight motorcycles both in India and abroad. The company’s performance reflects improving retail sentiment, steady expansion of its product portfolio, and growing interest from younger and premium-segment consumers. A combination of stable production, rising export traction, and increasing brand loyalty contributed to this robust growth.

Glenmark Pharmaceuticals reported a sharp 72% surge in its second-quarter profit, driven primarily by a milestone payment from its strategic licensing agreement with U.S.-based biopharmaceutical major AbbVie. The strong quarterly showing underscores the company’s ability to monetize its research pipeline while strengthening its financial position through partnerships that enhance global market access. Improved profitability comes at a crucial time for India’s pharmaceutical sector, which continues to focus on innovation-led growth and regulatory compliance.